COMPARISON OF GABAPENTIN AND METOCLOPRAMIDE FOR PREVENTION OF DELAYED ONSET CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: A RANDOMIZED OPEN LABEL CLINICAL TRIAL